微化学是关于未来怀孕的信息来源
1Department of Biological Sciences, Royal Holloway, University of London, Egham TW20 0EX, UK.
Proceedings. Biological sciences
|August 23, 2023
概括
孕产妇的微化学细胞,即母亲的胎儿细胞,可能是未来怀孕风险的信号. 这项研究提出胎儿细胞向胎儿告知后续怀孕中的遗传关系,可能会影响母亲的健康.
科学领域:
- 生殖免疫学 生殖免疫学
- 发展生物学 发展生物学
- 遗传学 是一个遗传学.
背景情况:
- 胎儿细胞在怀孕期间转移到母亲身上,从而产生母亲的微化学性.
- 这些微化学细胞从所有怀孕中积累起来,与生殖和自身免疫性疾病有关.
- 微化学细胞的确切功能在很大程度上是未知的.
研究的目的:
- 为微化学细胞提出一种新的功能:告知胎儿关于母亲兄弟姐妹未来的遗传关系.
- 根据遗传可能性假设一个机制,胎儿细胞根据遗传可能性调节母亲的免疫反应.
主要方法:
- 基于现有关于胎儿微化学和免疫学的文献的概念框架.
- 胎儿细胞转移和母亲免疫反应动态的理论建模.
主要成果:
- 胎儿细胞可以作为对胎儿关于未来兄弟姐妹的遗传组成的信号.
- 当遗传相关性不太可能时,预计会增加胎儿细胞数量,从而引起更强烈的母体免疫反应.
- 这种机制可以解释微化学细胞和子宫前之间的关联,特别是在基因多样化的母体微生物组中.
结论:
- 微化学细胞在关于未来生殖遗传风险的胎儿-母亲沟通中发挥着至关重要的作用.
- 拟议的机制为妊娠并发症和自身免疫性疾病的病因提供了新的视角.
- 需要进一步的研究和临床验证来证实这些假设及其诊断/治疗影响.
相关概念视频
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


